Fluconazole + Micafungin
ApprovedWithdrawn 1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Candidiasis
Conditions
Candidiasis, Sepsis
Trial Timeline
Aug 1, 2006 → Dec 1, 2008
NCT ID
NCT00304772About Fluconazole + Micafungin
Fluconazole + Micafungin is a approved stage product being developed by Astellas Pharma for Candidiasis. The current trial status is withdrawn. This product is registered under clinical trial identifier NCT00304772. Target conditions include Candidiasis, Sepsis.
What happened to similar drugs?
4 of 20 similar drugs in Candidiasis were approved
Approved (4) Terminated (3) Active (13)
Hype Score Breakdown
Clinical
20
Activity
0
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00304772 | Approved | Withdrawn |
Competing Products
20 competing products in Candidiasis
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Micafungin | Astellas Pharma | Phase 1 | 29 |
| Isavuconazole + Caspofungin + Voriconazole | Astellas Pharma | Phase 3 | 40 |
| Micafungin + fluconazole | Astellas Pharma | Phase 3 | 40 |
| Micafungin (Mycamine) | Astellas Pharma | Phase 1 | 29 |
| Micafungin + Caspofungin | Astellas Pharma | Phase 3 | 40 |
| Micafungin + Fluconazole | Astellas Pharma | Phase 3 | 40 |
| Micafungin | Astellas Pharma | Phase 2 | 35 |
| micafungin + caspofungin | Astellas Pharma | Phase 3 | 40 |
| micafungin + amphotericin B deoxycholate | Astellas Pharma | Phase 3 | 32 |
| FK463 | Astellas Pharma | Phase 2 | 35 |
| Micafungin + Liposomal Amphotericin B | Astellas Pharma | Phase 3 | 40 |
| SHR8008 + Fluconazole | Jiangsu Hengrui Medicine | Phase 3 | 36 |
| SHR8008 capsule + Fluconazole capsule | Jiangsu Hengrui Medicine | Phase 3 | 36 |
| L-743,872 | Merck | Pre-clinical | 26 |
| Caspofungin | Merck | Phase 2 | 35 |
| L-743,872 | Merck | Phase 2 | 27 |
| Caspofungin + Amphotericin B Deoxycholate | Merck | Phase 2 | 27 |
| Caspofungin acetate + Placebo | Merck | Phase 2 | 27 |
| Caspofungin + Normal Saline | Merck | Approved | 43 |
| caspofungin acetate | Merck | Phase 3 | 40 |